Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.43 |
| ▸ | NPC1 | O15118 | 8/20 | 0.43 |
| ▸ | RAB9A | P51151 | 7/20 | 0.43 |
| ▸ | MEN1 | O00255 | 7/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | GAA | P10253 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | TP53 | P04637 | 5/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.40 |
| ▸ | PKM | P14618 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20980449 | 0.83 | KDM4E (0.46) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL25712813 | 0.83 | MEN1 (0.41) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL20980557 | 0.79 | CYP11B2 (0.34) | GFERNPSR1 | |
| SCHEMBL20980510 | 0.78 | CYP11B2 (0.35) | — | |
| SCHEMBL20980469 | 0.78 | KDM4E (0.44) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL16692197 | 0.76 | MEN1 (0.57) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL16692171 | 0.71 | ALDH1A1 (0.56) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL16692167 | 0.71 | MEN1 (0.54) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL16692191 | 0.70 | KDM4E (0.64) | KDM4ENPC1RAB9AMEN1KMT2A | |
| SCHEMBL22705796 | 0.70 | KDM4E (0.48) | KDM4ENPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11214587-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-01-04 | — | — | US | disclosed |
| US-20190135843-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11214587-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OPRD1 | KDM4E 3754/4885NPC1 3147/4885RAB9A 1983/4885 |
| US-20190135843-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OPRD1 | KDM4E 3754/4885NPC1 3147/4885RAB9A 1983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.